Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02338219
Other study ID # U1111-1159-6256
Secondary ID
Status Completed
Phase Phase 1/Phase 2
First received August 22, 2014
Last updated January 11, 2015
Start date May 2013
Est. completion date February 2014

Study information

Verified date January 2015
Source Al-Azhar University
Contact n/a
Is FDA regulated No
Health authority Egypt: Ministry of Higher Education
Study type Interventional

Clinical Trial Summary

The purpose of this study is t o evaluate levator ani morphology following normal vaginal delivery and cesarean section (elective and emergent), using three-dimensional (3D) ultrasound, and to study the effect of mode of delivery on female sexual function.


Description:

1. transperineal pelvic floor ultrasound applied for the submitted 120 women "primiparae" (40 women after normal vaginal delivery), (40 women after urgent cesarean section), (40 women after elective cesarean section), in early postpartum period (48 to 72) hours postpartum, to evaluate levator ani morphology.

2. answering of the validated female sexual function index (F.S.F.I) three months postpartum period for same cases submitted to ultrasound.


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date February 2014
Est. primary completion date February 2014
Accepts healthy volunteers No
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- primiparae in early postpartum period (48 hours to72 hours). written consent was taken. easy communicable, reachable women for further requirements.

Exclusion Criteria:

- Refused consent. 2. Previous vaginal or cesarean delivery. 3. Severe mental illness. 4. Severe physical handicap or difficulties in communication. 5. Women without postpartum active sexual life or separate from their spouse. 6. Past history of sexual dysfunction.

Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Intervention

Other:
postpartum female pelvic floor muscle affection
transperineal pelvic floor ultrasound applied for the submitted 120 women "primiparae" (40 women after normal vaginal delivery), (40 women after urgent cesarean section), (40 women after elective cesarean section), in early postpartum period (48 to 72) hours postpartum, to evaluate levator ani morphology.
postpartum sexual function in Egyptian women.
answering of the validated female sexual function index (F.S.F.I) three months postpartum period for same cases submitted to ultrasound.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Al-Azhar University

Outcome

Type Measure Description Time frame Safety issue
Primary Pelvic floor muscle strength as assessed by three/four dimensional translabial pelvic floor ultrasound had worst morbidity after normal vaginal delivery early postpartum period (48 to 72) hours postpartum Yes
Secondary Sexual function of pelvic floor as assessed by the validated female sexual function index questionnaire was impaired in all women after delivery at 3 months after delivery Yes
See also
  Status Clinical Trial Phase
Completed NCT02245386 - Effects of Pregnancy and Childbirth on Pelvic Floor Morphology and Sexual Function in Egyptian Women N/A